New incident report
Incident Report Number: 2020-2300
Registrant Reference Number: 2019-CA-000199
Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation
Address: 400 Plaza Drive
City: Secaucus
Prov / State: New Jersey
Country: USA
Postal Code: 07094-3688
Domestic Animal
Country: CANADA
Prov / State: ONTARIO
Unknown
PMRA Registration No. 29930 PMRA Submission No. EPA Registration No.
Product Name: Hartz UltraGuard OneSpot Flea and Tick Cat Drops
Yes
Unknown
Site: Animal / Usage sur un animal domestique
Unknown
Animal's Owner
Cat / Chat
Domestic Shorthair
1
Male
4
7
lbs
Skin
Unknown / Inconnu
>30 min <=2 hrs / >30 min <=2 h
System
>8 hrs <=24 hrs / > 8 h < = 24 h
No
No
Fully Recovered / Complètement rétabli
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On an unspecified date in approximately 2019, a 4 year old, 7 pound, neutered, male, Domestic Shorthair cat, in unknown condition, with no known concomitant medical condition, was administered 1 tube of Hartz UltraGuard OneSpot Flea and Tick Cat Drops (S Methoprene) via the topical route by the animal owner. Approximately 1 hour post application, the cat exhibited vomiting, diarrhea, and generalized erythema. Approximately 24 hours post application, the clinical signs resolved and the cat recovered without medical intervention. The cat was administered the same product and also an unspecified Hartz shampoo on an unspecified date, prior. The cat exhibited the same clinical signs approximately 1 hour post each product's application. The clinical signs resolved and the cat recovered approximately 24 hours later, without medical intervention. No further information was received in this case.
Minor
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.